$PKBK Cashflow Statement | Understand Stock

$PKBK

$33.05 -$0.17 (0.51%) Close

$PKBK Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net income
Cash Flows from Operating Activities
Net income attributable to Company
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Provision for loan losses
Financing Receivable, Excluding Accrued Interest, Credit Loss Expense (Reversal)
Provision for credit losses
Increase in value of bank-owned life insurance
Net gain on OREO
Gain on sale of SBA loans
SBA loans originated for sale
Proceeds from sale of SBA loans originated for sale
OREO writeoff
Net accretion of purchase premiums and discounts on securities
Stock based compensation
Decrease in deferred income tax
(Increase) decrease in deferred income tax

Net changes in:
Decrease in accrued interest receivable and other assets
Increase in accrued interest payable and other accrued liabilities
Net cash provided by operating activities
Repayments and maturities of investment securities available for sale
Repayments and maturities of investment securities held to maturity

Cash Flows from Investing Activities
Repayments and maturities of investment securities available for sale
Repayments and maturities of investment securities held to maturity
Purchases of investment securities held to maturity
Net decrease (increase) in loans
Purchase of investment securities
Bank-owned life insurance additional purchase
Net increase in loans
Purchases of bank premises and equipment
(Purchases) sales of bank premises and equipment
Proceeds from sale of OREO, net
Redemptions (purchases) of restricted stock
Proceeds from bank owned life insurance policy
Redemptions of restricted stock
Purchases of restricted stock
Net cash used in investing activities

Cash Flows from Financing Activities
Cash dividends
Proceeds from exercise of stock options
Net proceeds from issuance of subordinate debt
Earnings distribution from non-controlling interest
(Decrease) increase in FHLBNY short-term borrowings
Net (decrease) increase in other borrowed funds
Increase (decrease) in FHLBNY long-term borrowings
Net decrease in other borrowed funds
Treasury stock purchase
Conversion of Series B preferred stock
Excise tax payment on purchase of treasury stock
Repayment of sub debt
Increase in FHLBNY short-term borrowings
Decrease in FHLBNY long-term borrowings
Net increase (decrease) in noninterest-bearing deposits
Net increase in interest-bearing deposits
Net cash provided by financing activities
(Decrease) increase in cash and cash equivalents
Cash and Cash Equivalents, January 1,
Cash and Cash Equivalents, December 31,

Supplemental Disclosure of Cash Flow Information:
Interest paid
Income taxes paid
Federal income taxes paid
State taxes paid
Non-cash Investing and Financing Items
Loans transferred to OREO
Accrued dividends payable

Comments